Fulda, 20 November 2024 – Trialytix, the leading provider of innovative solutions for budgeting and cost management in clinical trials, is pleased to announce the appointment of Tim Geisendörfer as the new Chief Technology Officer. With over 10 years of entrepreneurial experience and a solid expertise in developing high-performance software solutions, Tim will drive the technological vision of Trialytix and support the company in its mission to assist life sciences companies in optimising their budgeting and cost processes.
Tim brings experience as the founder of the international software agency InnoGE, where he continues to serve as founder and shareholder. In his role at Trialytix, he will take on the technological strategy and ensure the further optimisation of Trialytix’s all-in-one software while integrating innovative technologies.
“We are excited to welcome Tim to our team. His expertise will help us scale our technology platform and strengthen our competitive edge in the field of clinical trials” , says Philipp Gerk, CEO of Trialytix.
Trialytix is committed to focussing on the budgeting and cost management of life sciences companies and enhancing the efficiency and success of clinical trial projects through data-driven decisions.
About Trialytix: Trialytix is a leading provider of software solutions for budgeting and cost management in clinical trials. Our innovative platform supports life sciences companies in efficiently managing their research projects and making data-driven decisions.